Jonathan Lee, MD, MSc

Jonathan Lee, MD, MSc, is a chief Hematology/Oncology Fellow at Weill Cornell Medicine.

Articles by Jonathan Lee, MD, MSc

Advances in EGFR-Mutant, HER2-Positive, and Oncogene-Driven NSCLC Highlighted at CFS: With Benjamin P. Levy, MD, and Jonathan W. Lee, MD, MSc

ByBenjamin P. Levy, MD,Jonathan Lee, MD, MSc

November 14th 2025

Benjamin P. Levy, MD, and Jonathan W. Lee, MD, MSc discuss advances in EGFR-Mutant, HER2-Positive, and Oncogene-Driven NSCLC Highlighted at CFS.

Jonathan Lee, MD, MSc, Weill Cornell Medicine.

Understanding Your New Role as a Hematology/Oncology Fellow

ByJonathan Lee, MD, MSc

September 3rd 2025

The chief oncology/hematology fellow at Weill Cornell Medicine details everything that he wishes he had known entering his first year of fellowship.

Trending on OncLive

Dr Wander on the Evolving First-Line and Post–T-DXd Landscape in HER2+ Metastatic Breast Cancer

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

Dr Levy on Where Iza-Bren May Fit Following Osimertinib In EGFR-Mutated NSCLC

Dr Levy on How the EGFR-Targeted Therapy Landscape Has Evolved in NSCLC

Detalimogene Responses Improve With Longer Follow-Up in BCG-Unresponsive NMIBC Ahead of BLA Submission